Last updated on April 2017

Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders:


Brief description of study

A global post approval study to collect safety and effectiveness data related to ExAblate Neuro for the treatment of certain disorders such as Essential Tremor, Parkinson's Movement Disorders, or Neuropathic Pain within the thalamus and/or pallidum.

Detailed Study Description

A global, multi-center, open-label, observational registry to capture safety and effectiveness data related to ExAblate Neuro, an MRI guided focused ultrasound device designed to lesion tissue deep within the brain using sound waves without the need for craniotomy. This registry includes certain regional and country specific approved thalamotomy and pallidotomy procedures using ExAblate Neuro for the treatment of various neurologic disorders such as essential tremor, Parkinson's movement disorders, and neuropathic pain. Treatment targets/indications are country/region dependent based on approved labeling within that region.

Clinical Study Identifier: NCT03100474

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Menashe Zaaroor, MD

Rambam Healthcare Campus
Haifa, Israel
  Connect »

Simon Israeli-Korn, MD

Sheba Medical Center
Ramat Gan, Israel
  Connect »